This new approach, based on natural selection, dramatically improves the reliability of large language models for practical ...

Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

The laboratory of the latest Nobel Prize winner in Chemistry David Baker, headed by researcher Susana Vázquez, talks about ...

Introduction - The year 2024 marked a pivotal time in artificial intelligence, where aspirations transformed into concrete ...

Gemini is a large language model (LLM) developed by Google DeepMind, and Gemini Advanced is its premium version, offering access to more powerful AI models and features. While everyone with a ...

Google DeepMind, established in April 2023, is a unit formed with DeepMind and the Brain team from Google Research joining forces. It is the AI R&D division behind many of Google’s more recent AI ...

AI technologies are changing the future of medicine: AtomNet, Holiverse, IBM Arterys, Google DeepMind Health and Curology This article looks at five innovative projects - AtomNet, Holiverse ...

As it looks to accelerate the pace of its AI development, Google is further streamlining the teams building its AI services, platforms, and tools. On Thursday, Logan Kilpatrick, who leads product ...